Bos mutus (wild yak): 102282890
Help
Entry
102282890 CDS
T02919
Symbol
IL1B
Name
(RefSeq) interleukin-1 beta
KO
K04519
interleukin 1 beta
Organism
bom
Bos mutus (wild yak)
Pathway
bom01523
Antifolate resistance
bom04010
MAPK signaling pathway
bom04060
Cytokine-cytokine receptor interaction
bom04064
NF-kappa B signaling pathway
bom04217
Necroptosis
bom04380
Osteoclast differentiation
bom04620
Toll-like receptor signaling pathway
bom04621
NOD-like receptor signaling pathway
bom04623
Cytosolic DNA-sensing pathway
bom04625
C-type lectin receptor signaling pathway
bom04640
Hematopoietic cell lineage
bom04657
IL-17 signaling pathway
bom04659
Th17 cell differentiation
bom04668
TNF signaling pathway
bom04750
Inflammatory mediator regulation of TRP channels
bom04932
Non-alcoholic fatty liver disease
bom04933
AGE-RAGE signaling pathway in diabetic complications
bom04936
Alcoholic liver disease
bom04940
Type I diabetes mellitus
bom05010
Alzheimer disease
bom05020
Prion disease
bom05022
Pathways of neurodegeneration - multiple diseases
bom05132
Salmonella infection
bom05133
Pertussis
bom05134
Legionellosis
bom05135
Yersinia infection
bom05140
Leishmaniasis
bom05142
Chagas disease
bom05143
African trypanosomiasis
bom05144
Malaria
bom05146
Amoebiasis
bom05152
Tuberculosis
bom05162
Measles
bom05163
Human cytomegalovirus infection
bom05164
Influenza A
bom05168
Herpes simplex virus 1 infection
bom05171
Coronavirus disease - COVID-19
bom05321
Inflammatory bowel disease
bom05323
Rheumatoid arthritis
bom05332
Graft-versus-host disease
bom05417
Lipid and atherosclerosis
bom05418
Fluid shear stress and atherosclerosis
Brite
KEGG Orthology (KO) [BR:
bom00001
]
09130 Environmental Information Processing
09132 Signal transduction
04010 MAPK signaling pathway
102282890 (IL1B)
04064 NF-kappa B signaling pathway
102282890 (IL1B)
04668 TNF signaling pathway
102282890 (IL1B)
09133 Signaling molecules and interaction
04060 Cytokine-cytokine receptor interaction
102282890 (IL1B)
09140 Cellular Processes
09143 Cell growth and death
04217 Necroptosis
102282890 (IL1B)
09150 Organismal Systems
09151 Immune system
04640 Hematopoietic cell lineage
102282890 (IL1B)
04620 Toll-like receptor signaling pathway
102282890 (IL1B)
04621 NOD-like receptor signaling pathway
102282890 (IL1B)
04623 Cytosolic DNA-sensing pathway
102282890 (IL1B)
04625 C-type lectin receptor signaling pathway
102282890 (IL1B)
04659 Th17 cell differentiation
102282890 (IL1B)
04657 IL-17 signaling pathway
102282890 (IL1B)
09157 Sensory system
04750 Inflammatory mediator regulation of TRP channels
102282890 (IL1B)
09158 Development and regeneration
04380 Osteoclast differentiation
102282890 (IL1B)
09160 Human Diseases
09172 Infectious disease: viral
05171 Coronavirus disease - COVID-19
102282890 (IL1B)
05164 Influenza A
102282890 (IL1B)
05162 Measles
102282890 (IL1B)
05168 Herpes simplex virus 1 infection
102282890 (IL1B)
05163 Human cytomegalovirus infection
102282890 (IL1B)
09171 Infectious disease: bacterial
05132 Salmonella infection
102282890 (IL1B)
05135 Yersinia infection
102282890 (IL1B)
05133 Pertussis
102282890 (IL1B)
05134 Legionellosis
102282890 (IL1B)
05152 Tuberculosis
102282890 (IL1B)
09174 Infectious disease: parasitic
05146 Amoebiasis
102282890 (IL1B)
05144 Malaria
102282890 (IL1B)
05140 Leishmaniasis
102282890 (IL1B)
05142 Chagas disease
102282890 (IL1B)
05143 African trypanosomiasis
102282890 (IL1B)
09163 Immune disease
05323 Rheumatoid arthritis
102282890 (IL1B)
05321 Inflammatory bowel disease
102282890 (IL1B)
05332 Graft-versus-host disease
102282890 (IL1B)
09164 Neurodegenerative disease
05010 Alzheimer disease
102282890 (IL1B)
05020 Prion disease
102282890 (IL1B)
05022 Pathways of neurodegeneration - multiple diseases
102282890 (IL1B)
09166 Cardiovascular disease
05417 Lipid and atherosclerosis
102282890 (IL1B)
05418 Fluid shear stress and atherosclerosis
102282890 (IL1B)
09167 Endocrine and metabolic disease
04940 Type I diabetes mellitus
102282890 (IL1B)
04936 Alcoholic liver disease
102282890 (IL1B)
04932 Non-alcoholic fatty liver disease
102282890 (IL1B)
04933 AGE-RAGE signaling pathway in diabetic complications
102282890 (IL1B)
09176 Drug resistance: antineoplastic
01523 Antifolate resistance
102282890 (IL1B)
09180 Brite Hierarchies
09183 Protein families: signaling and cellular processes
04052 Cytokines and neuropeptides [BR:
bom04052
]
102282890 (IL1B)
00536 Glycosaminoglycan binding proteins [BR:
bom00536
]
102282890 (IL1B)
Cytokines and neuropeptides [BR:
bom04052
]
Cytokines
Interleukins
102282890 (IL1B)
Glycosaminoglycan binding proteins [BR:
bom00536
]
Heparan sulfate / Heparin
Cytokines
102282890 (IL1B)
BRITE hierarchy
SSDB
Ortholog
Paralog
Gene cluster
GFIT
Motif
Pfam:
IL1
IL1_propep
TTC5_OB
Motif
Other DBs
NCBI-GeneID:
102282890
NCBI-ProteinID:
XP_005890050
UniProt:
L8IVA9
LinkDB
All DBs
Position
11:60163296..60201028
Genome browser
AA seq
266 aa
AA seq
DB search
MATVPEPINEMMAYYSDENELLFEADGPKQMKSCIQHLDLGSMGDGNIQLQISHQFYNKS
FRQVVSVIVAMEKLRNSAYAHVFHDDDLRSILSFIFEEEPVIFETSSDEFLCDAPVQSVK
CKLQDREQKSLVLASPCVLKALHLLSQEMNREVVFCMSFVQGEERDNKIPVALGIKDKNL
YLSCVKKGDTPTLQLEEVDPKVYPKRNMEKRFVFYKTEIKNTVEFESVLYPNWYISTSQI
EERPVFLGHFRGGQDITDFRMETLSP
NT seq
801 nt
NT seq
+upstream
nt +downstream
nt
atggcaaccgtacctgaacccatcaacgaaatgatggcttactacagtgacgagaatgag
ctgttatttgaggctgatggccccaaacagatgaagagctgcatccaacacctggacctc
ggttccatgggagatggaaacatccagctgcagatttctcaccagttctacaacaaaagc
ttcaggcaggtggtgtcggtcatcgtggccatggagaagctgaggaacagtgcctacgca
catgtcttccatgatgatgacctgaggagcatcctttcattcatctttgaagaagagcct
gtcatcttcgaaacgtcctccgacgagtttctgtgtgacgcacccgtgcagtcagtaaag
tgcaaactccaggacagagagcaaaaatccctggtgctggctagcccatgtgtgctgaag
gctctccacctcctctcacaggaaatgaaccgagaagtggtgttctgcatgagcttcgtg
caaggagaggaaagagacaacaagattcctgtggccttgggtatcaaggacaagaatcta
tacctgtcttgtgtgaaaaaaggtgatacgcccaccctgcagctggaggaagtagacccc
aaagtctaccccaagaggaatatggaaaagcgttttgtcttctacaagacagaaatcaag
aatacagttgaatttgagtctgtcctgtaccctaactggtacatcagcacttctcaaatc
gaagaaaggcccgtcttcctgggacattttcgaggtggccaggatataactgacttcaga
atggaaaccctctctccctaa
DBGET
integrated database retrieval system